Thus, one possibility to investigate in the future is that the increased expression of both MHCII and CD86 in March1-deficient mice blunts the Th2 response to the allergen and/or activates Th17 cells, which are known to increase neutrophil influx in airways of mice with allergic asthma [48]. The gene discussed is MARCHF1; the disease is allergic asthma.